/PRNewswire/ Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of underserved cancers,.
- Building the team with experienced biotech experts and renowned leaders in the ADC field - Underscores company's commitment to progressing lead program on novel ADC target uPARAP COPENHAGEN